Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  Pacific Biosciences of California    P09

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Deutsche Boerse Ag
02/13/2017 02/14/2017 02/15/2017 02/16/2017 02/17/2017 Date
4.722(c) 4.933(c) 4.906(c) 5.095(c) 4.999(c) Last
0 843 800 250 0 Volume
+1.46% +4.47% -0.55% +3.85% -1.88% Change
More quotes
Financials ($)
Sales 2017 113 M
EBIT 2017 -79,4 M
Net income 2017 -83,0 M
Debt 2017 0,70 M
Yield 2017 -
Sales 2018 145 M
EBIT 2018 -60,1 M
Net income 2018 -63,0 M
Finance 2018 0,22 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 4,37x
EV / Sales2018 3,41x
Capitalization 494 M
More Financials
Company
Pacific Biosciences of California, Inc. engages in the research, development, and manufacture of sequencing systems for genetic analysis.It operates through the following geographical segments: North America, Europe, and Asia.It offers deoxyribonucleic acid sequencing, third generation sequencing... 
More about the company
Surperformance© ratings of Pacific Biosciences of Cal
Trading Rating : Investor Rating :
More Ratings
Latest news on PACIFIC BIOSCIENCES OF CAL
02/13 SMRT Sequencing to be Featured in More Than 35 Presentations at the Annual AG..
02/02 PACIFIC BIOSCIENCES OF CALIFORNIA : reports 4Q loss
02/02 PACIFIC BIOSCIENCES OF CALIFORNIA, I : Other Events, Financial Statements and Ex..
02/02 PACIFIC BIOSCIENCES OF CALIFORNIA, I : Results of Operations and Financial Condi..
02/02 Pacific Biosciences Announces Fourth Quarter 2016 Financial Results
02/02 PACIFIC BIOSCIENCES OF CALIFORNIA : Patent Issued for Modular Nucleotide Composi..
02/02 PACIFIC BIOSCIENCES OF CALIFORNIA : Patent Issued for Filter Architecture for An..
01/27 Pacific Biosciences of California, Inc. Fourth Quarter 2016 Financial Results..
01/17 PACIFIC BIOSCIENCES OF CALIFORNIA : Novogene Agrees to Buy Ten PacBio Sequel Sys..
01/16 Novogene Agrees to Buy Ten PacBio Sequel Systems for DNA Sequencing Services
More news
Sector news : Advanced Medical Equipment & Technology - NEC
02/09 Infineon, Cree warn U.S. might block Wolfspeed deal
02/02 EU probes online sales in electronics, video games, hotels
01/31DJTHERMO FISHER SCIENTIFIC : Earnings, Sales Rise
01/31DJDANAHER : Revenue, Profit Rise
01/30DJEUROPEAN MORNING BRIEFING : Corporate Events
More sector news : Advanced Medical Equipment & Technology - NEC
Advertisement
Chart PACIFIC BIOSCIENCES OF CAL
Duration : Period :
Pacific Biosciences of Cal Technical Analysis Chart | P09 | US69404D1081 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 7,42 $
Spread / Average Target 39%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Michael W. Hunkapiller Executive Chairman, President & CEO
Susan K. Barnes CFO, Principal Accounting Officer & Executive VP
Stephen W. Turner Chief Technical Officer & Vice President
Jonas Korlach Chief Scientific Officer
Brook H. Byers Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PACIFIC BIOSCIENCES OF..36.73%494
THERMO FISHER SCIENTIF..12.43%62 667
DANAHER CORPORATION7.98%58 138
BOSTON SCIENTIFIC CORP..17.38%34 573
INTUITIVE SURGICAL, IN..14.27%28 107
PHILIPS-4.28%27 388
More Results